Bud Romine  - The first patient taking Gleevec -  Chronic Myeloid Leukemia

Bud Romine was the first  patient in the world starting to take Gleevec in June 25, 1998

''For the first time, patients with a specific form of leukemia will receive an investigational drug therapy aimed precisely at the molecules causing their cancer. The first patient, 68-year-old Bud Romine from Tillamook, Ore., will take his first dose of the experimental drug on Thursday, June 25, 1998, at Oregon Health Sciences University.''
More Information at   OHSU Scientists Begin Human Trials Of A Drug Aimed At The Underlying Cause Of Chronic Myelogenous Leukemia

The first day of clinical trials for Gleevec, Bud and Yvonne        from DNA LearningCenter     VIDEO

The magic pills, Bud and Yvonne                                             from DNA LearningCenter    VIDEO

Getting the diagnosis of chronic myeloid leukemia, Bud            from DNA LearningCenter     VIDEO

Bloodcount returns to normal with Gleevec, Bud and Yvonne     from DNA LearningCenter     VIDEO

Cancer Treatment  Breakthroughs
May 2007, www.oprah.com







.